股票行情快报：天臣医疗（688013）11月13日主力资金净买入2103.70万元

Core Viewpoint - Tianchen Medical (688013) has shown a positive stock performance with a closing price of 57.21 yuan, reflecting a 1.72% increase on November 13, 2025, amidst varying capital flows [1][2]. Financial Performance - For the first three quarters of 2025, Tianchen Medical reported a main revenue of 244 million yuan, a year-on-year increase of 20.66% [3]. - The net profit attributable to shareholders reached 71.95 million yuan, up 68.29% year-on-year, while the non-recurring net profit was 66.20 million yuan, increasing by 71.85% [3]. - In Q3 2025, the company achieved a quarterly main revenue of 87.66 million yuan, a 26.4% year-on-year growth, with a quarterly net profit of 23.73 million yuan, up 70.74% [3]. Market Position - Tianchen Medical's total market capitalization stands at 4.643 billion yuan, ranking 77th in the medical device industry [3]. - The company has a net asset of 600 million yuan, with a net profit of 71.95 million yuan, indicating a competitive position in terms of profitability with a net profit margin of 29.51% [3]. - The company's price-to-earnings ratio (P/E) is 48.4, which is lower than the industry average of 60.24, suggesting a relatively favorable valuation [3]. Capital Flow Analysis - On November 13, 2025, the net inflow of main funds was 21.04 million yuan, accounting for 13.19% of the total transaction volume, while retail investors experienced a net outflow of 16.68 million yuan, representing 10.45% of the total [1][2]. - Over the past five days, the stock has seen fluctuations in capital flow, with notable net inflows and outflows from different investor categories [2].